9 Jefferies Group Evolent Health Trades
Jefferies Group acquired 255 Thousand Evolent Health shares worth $2.21 Million. That's 0.03% of their equity portfolio (369th largest holding). The first Evolent Health trade was made in Q4 2022. Since then Jefferies Group bought shares three more times and sold shares on five occasions. The investor's estimated purchase price is $5.77 Million, resulting in a loss of 62%.
Avg closing price
Price range
Increased shares by 276.0% (+187 Thousand shares)
Q4 2024
Avg closing price
$17.33
Price range
$10.87
-
$27.13
Sold 61.6% shares (-109 Thousand shares)
Q3 2024
Avg closing price
$25.78
Price range
$18.41
-
$32.97
Increased shares by 16313.8% (+176 Thousand shares)
Q2 2024
Avg closing price
$25.54
Price range
$19.12
-
$31.93
Sold 89.0% shares (-8.67 Thousand shares)
Q1 2024
Avg closing price
$31.91
Price range
$29.41
-
$34.72
Sold 69.7% shares (-22.5 Thousand shares)
Q4 2023
Avg closing price
$28.30
Price range
$23.63
-
$33.52
Sold 46.6% shares (-28.1 Thousand shares)
Q3 2023
Avg closing price
$27.80
Price range
$25.00
-
$31.40
Increased shares by 66.2% (+24 Thousand shares)
Q2 2023
Avg closing price
$32.33
Price range
$28.05
-
$36.44
Sold 11.2% shares (-4.59 Thousand shares)
Q1 2023
Avg closing price
$31.62
Price range
$26.35
-
$35.80
New holding (+40.9 Thousand shares)
Q4 2022
Avg closing price
$28.67
Price range
$21.96
-
$37.41
